Insulet Other Assets vs Total Current Assets Analysis
PODD Stock | USD 166.19 2.02 1.23% |
Insulet financial indicator trend analysis is infinitely more than just investigating Insulet recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Insulet is a good investment. Please check the relationship between Insulet Other Assets and its Total Current Assets accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.
Other Assets vs Total Current Assets
Other Assets vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Insulet Other Assets account and Total Current Assets. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Insulet's Other Assets and Total Current Assets is 0.51. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Insulet, assuming nothing else is changed. The correlation between historical values of Insulet's Other Assets and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Insulet are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Other Assets i.e., Insulet's Other Assets and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.51 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Other Assets
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Insulet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Insulet current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.At present, Insulet's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 76.04, whereas Discontinued Operations is forecasted to decline to (2 M).
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 500K | 9.8M | 28.9M | 30.3M | Tax Provision | 3.7M | 5.2M | 9.1M | 9.6M |
Insulet fundamental ratios Correlations
Click cells to compare fundamentals
Insulet Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Insulet fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.1B | 1.9B | 2.0B | 2.3B | 2.6B | 2.7B | |
Total Stockholder Equity | 75.9M | 603.6M | 556.3M | 476.4M | 732.7M | 769.3M | |
Net Debt | 511.8M | 96.1M | 457.2M | 727.1M | 798.1M | 838.0M | |
Cash | 376.1M | 947.6M | 791.6M | 674.7M | 650.7M | 683.2M | |
Other Assets | 25M | 79M | 106.1M | 147.1M | 1.0 | 0.95 | |
Cash And Short Term Investments | 376.1M | 947.6M | 791.6M | 674.7M | 704.2M | 739.4M | |
Common Stock Shares Outstanding | 62.3M | 65.9M | 68.6M | 69.9M | 73.6M | 44.7M | |
Liabilities And Stockholders Equity | 1.1B | 1.9B | 2.0B | 2.3B | 2.6B | 2.7B | |
Other Stockholder Equity | 749M | 1.3B | 1.2B | 1.0B | 1.1B | 620.4M | |
Total Liab | 1.1B | 1.3B | 1.5B | 1.8B | 1.9B | 1.9B | |
Total Current Assets | 591M | 1.2B | 1.3B | 1.3B | 1.6B | 1.6B | |
Short Long Term Debt Total | 887.9M | 1.0B | 1.2B | 1.4B | 1.4B | 1.5B | |
Other Current Liab | 96.4M | 132.7M | 162.5M | 290.3M | 363.7M | 381.9M | |
Total Current Liabilities | 157.7M | 207.8M | 228.8M | 364.7M | 451.2M | 473.8M | |
Property Plant And Equipment Net | 399.4M | 478.7M | 536.5M | 599.9M | 692.8M | 727.4M | |
Current Deferred Revenue | 3.2M | 5.4M | 3.5M | 16.1M | 15.4M | 16.2M | |
Retained Earnings | (672M) | (666.3M) | (649.5M) | (584.3M) | (378M) | (396.9M) | |
Accounts Payable | 54.5M | 54.1M | 37.7M | 30.8M | 19.2M | 19.7M | |
Non Current Assets Total | 551.9M | 624.2M | 719M | 937.1M | 1.0B | 1.1B | |
Non Currrent Assets Other | 41.1M | 77M | 106.1M | 210M | 178.7M | 187.6M | |
Non Current Liabilities Total | 909.3M | 1.1B | 1.3B | 1.4B | 1.4B | 1.5B | |
Other Current Assets | 31.1M | 63M | 74M | 86.9M | 99.8M | 104.8M | |
Property Plant And Equipment Gross | 399.4M | 478.7M | 715.7M | 834.6M | 958.1M | 1.0B | |
Accumulated Other Comprehensive Income | (1.2M) | 5.5M | (2.2M) | 20M | 8M | 8.4M | |
Other Liab | 7M | 17.8M | 14.9M | 8.3M | 9.5M | 5.4M | |
Long Term Debt | 887.9M | 1.0B | 1.2B | 1.4B | 1.4B | 1.4B | |
Net Receivables | 82.8M | 83.8M | 161M | 205.6M | 359.7M | 377.7M | |
Short Term Investments | 175.0M | 162.4M | 40.4M | 50.8M | 53.5M | 63.8M | |
Inventory | 101M | 154.3M | 303.2M | 346.8M | 402.6M | 422.7M | |
Property Plant Equipment | 399.4M | 478.7M | 536.5M | 599.9M | 689.9M | 724.4M | |
Net Tangible Assets | 22.9M | 535.1M | 479.9M | 349.2M | 401.6M | 421.7M | |
Good Will | 39.8M | 39.6M | 39.8M | 51.7M | 59.5M | 44.1M | |
Retained Earnings Total Equity | (672M) | (666.3M) | (649.5M) | (584.3M) | (525.9M) | (552.2M) | |
Long Term Debt Total | 887.9M | 1.0B | 1.2B | 1.4B | 1.6B | 1.7B | |
Capital Surpluse | 749M | 1.3B | 1.2B | 1.0B | 1.2B | 899.1M | |
Deferred Long Term Liab | 19.9M | 21.9M | 26.1M | 31.3M | 36.0M | 37.8M | |
Non Current Liabilities Other | 21.4M | 17.8M | 14.9M | 35.7M | 37.9M | 39.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insulet using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.